Skip to content

MEDMEX

Active
Private limited company (pre-2019)founded 1998active for 28 yearsSint-Jan-Baptistvoorplein 19, 1080 Sint-Jans-Molenbeek, BelgiumKBO/BCE: BE 0463.428.881
Summary

MEDMEX has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €684,002 and a net result of €125,987. Equity is growing by about 26% per year across the filed financial years. Its solvency ranks better than 79% of 4,950 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€1.0mtotal assets 2025
Staff
2.7 FTE
Equity
€684,002
Profit
€125,987
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
ALPHA MEDICALS · 100%
Accounts 1 day early0 of 2 deeds read
Why 96raises riskSector: Retail trade (NACE 47)lowers riskFounded in 1998Equity €684,002 (66.2% of total assets)Liquidity: current ratio 2.95, cash €120,027Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 70% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 91+16
equity 66.2% of total assets
Liquidity 50-2
short-term debt 33.8% · cash 11.6%
Profitability 84-11
return on assets 12.2%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,186 companies, NACE 47, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: 0.1%▲ +0.1 percentage points vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.2%▲ +0.1 percentage points vs 01-2026highest value 03-2026: 0.1%▼ -0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.95, compared with 2.05 in 2024; short-term debt: 33.8% and cash: 11.6% of total assets), and 33.8% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 78% on solvency, 50% on liquidity, 78% on profitability and 75% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Founded in 1998
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Equity €684,002 (66.2% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.95, cash €120,027
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 day early
2024
4 days late
2023
on the day
2022
on the day
2021
12 days early
2020
16 days early
2019
17 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 6 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end09-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Annual accounts filedfinancial year 2024 · full…
  3. Highest result from 2019 to 2025net €230,147 ▲183%

Key points

  • Caution: Result fell in 2025from €230,147 to €125,987 ▼ 45.3% View
  • Controlled by ALPHA MEDICALS 100% View
  • Positive: 5 profitable years in a rowprofit 2025: €125,987 5 years View

By topic

Financials

Financial year
2025
Total assets
€1.0m
Profit
€125,987
Solvency
66.2%
Total assets▼ 6.9%
Net result
20192025
Go to Financials

Timeline

Events
33
Since
2000
Next accounts
by 31-01-2027
  1. 30-06-2024Equity above €500,000
  2. 31-01-2024Annual accounts filed
  3. 31-01-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
26-05-1998
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.